These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 37495163)

  • 1. Comparing the sensitivity of cross-over and parallel study designs for QTc assessment: An analysis based on a single large study of moxifloxacin in 48 nonhuman primates.
    Leishman DJ; Holdsworth DL; Best DD; Roche BM
    J Pharmacol Toxicol Methods; 2023; 123():107299. PubMed ID: 37495163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysis.
    Chui RW; Baublits J; Chandra FA; Jones ZW; Engwall MJ; Vargas HM
    Clin Transl Sci; 2021 Nov; 14(6):2379-2390. PubMed ID: 34173339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
    Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
    Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the performance of contemporary, historical, and cross-lab controls in QTc assessment in conscious nonhuman primates.
    Abernathy MM; Best DD; Leishman DJ
    J Pharmacol Toxicol Methods; 2024; 127():107510. PubMed ID: 38705245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "One-Step" approach for QT analysis increases the sensitivity of nonclinical QTc analysis.
    Leishman DJ; Holdsworth DL; Lauver DA; Bailie MB; Roche BM
    Clin Transl Sci; 2023 Nov; 16(11):2253-2264. PubMed ID: 37726963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.
    Kambayashi R; Goto A; Izumi-Nakaseko H; Oikawa I; Ikeda N; Matsuda K; Takei Y; Matsumoto A; Kumagai Y; Sugiyama A
    J Pharmacol Sci; 2022 Nov; 150(3):191-199. PubMed ID: 36184124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration-QTc analysis.
    Engwall MJ; Baublits J; Chandra FA; Jones ZW; Wahlstrom J; Chui RW; Vargas HM
    Clin Transl Sci; 2023 Mar; 16(3):436-446. PubMed ID: 36369797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies.
    Baublits J; Vargas HM; Engwall MJ
    J Pharmacol Toxicol Methods; 2021; 109():107067. PubMed ID: 33857614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessments.
    Chaves AA; Ferraro JW; Yu J; Moye MJ; Yee KL; Li F; Steve DL; Lengel DJ; Regan CP
    J Pharmacol Toxicol Methods; 2024 Jun; 128():107525. PubMed ID: 38851600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay sensitivity in "Hybrid thorough QT/QTc (TQT)" study.
    Huang DP; Chen J; Dang Q; Tsong Y
    J Biopharm Stat; 2019; 29(2):378-384. PubMed ID: 30346877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.
    Taubel J; Naseem A; Harada T; Wang D; Arezina R; Lorch U; Camm AJ
    Br J Clin Pharmacol; 2010 Apr; 69(4):391-400. PubMed ID: 20406223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation.
    Holdsworth D; Best DD; Haist K; O'Donohue K; Phillips A; Abernathy MM; Roche B; Leishman DJ
    J Pharmacol Toxicol Methods; 2023; 120():107253. PubMed ID: 36806737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As.
    Rossman EI; Wisialowski TA; Vargas HM; Valentin JP; Rolf MG; Roche BM; Riley S; Pugsley MK; Nichols J; Li D; Leishman DJ; Kleiman RB; Greiter-Wilke A; Gintant GA; Engwall MJ; Delaunois A; Authier S
    J Pharmacol Toxicol Methods; 2023; 123():107270. PubMed ID: 37164235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
    Sechaud R; Dumortier T; Balez S
    Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
    de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P
    Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline selection in concentration-QTc modeling: impact on assay sensitivity.
    Huang DP; Chen J; Tsong Y
    J Biopharm Stat; 2021 Mar; 31(2):168-179. PubMed ID: 32873122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
    Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
    Kubitza D; Mueck W; Becka M
    Drug Saf; 2008; 31(1):67-77. PubMed ID: 18095747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.